Kalliga Kit
Product Images NDC 65862-887

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Kalliga (NDC 65862-887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Deso Ethi Fig1)

Bar chart depicting mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45+) comparing four groups: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers). Mortality rates increase with age and are highest among ever-users who are smokers, especially in the 45+ age group.*

FDA Label Image

Day-1 Starters: If Your Period Begins On A Day Other Than Sunday, Place The Day Label Strip That Starts With The First Day Of Your Period Here. (Deso Ethi Fig2)

A forest plot showing effect estimates (odds ratio/relative risk) with confidence intervals for multiple studies related to women's contraceptive use. The studies listed include NICHD Women's Contraceptive Study (2002), French E3N cohort Study (2005), Shangai Women's Health Study (2009), The Nurses' Health Study II (2010), Oxford Family Planning Association Study (2013), and Danish Sex Hormone Register Study (2017), among others. Each study's point estimate and confidence interval are visually represented, with corresponding numerical values displayed in a table to the right of the plot.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg Pouch Label)

Illustration showing a weekly tablet schedule for Kalliga (Desogestrel and Ethinyl Estradiol) contraceptive kit. The layout is a 4-week calendar with days Sunday through Saturday. Weeks 1 to 3 have white to off-white circles indicating active tablets, with arrows directing intake order. Week 4 shows green circles representing inactive tablets. The diagram includes labeling for tablet colors and days to guide proper use.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg Blister Carton)

Kalliga (Desogestrel and Ethinyl Estradiol Tablets USP) kit label showing the dosage strength of 0.15 mg/0.03 mg. The label indicates each pouch contains 28 tablets, distributed by Aurobindo Pharma USA, Inc. Additional information includes storage instructions, child resistance warning, and dosage directions. The label also features barcodes and trademark branding.*

FDA Label Image

Deso Ethi Fig5

Packaging label for Kalliga 0.15 mg/0.03 mg Desogestrel and Ethinyl Estradiol Tablets USP kit. The label indicates 6 pouches each containing 28 tablets, distributed by Aurobindo Pharma USA, Inc. The box includes storage instructions and safety warnings. The label features the Aurobindo logo and is marked Rx only.*

FDA Label Image

Chemical Structure (Deso Ethi Str)

Chemical structure diagrams of the active ingredients desogestrel and ethinyl estradiol, as labeled in the image. These structures illustrate the molecular frameworks of both compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.